Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Covance

Covance
M&A STATUS
10K-15K EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
11 INVESTMENTS
Description

Provider of comprehensive drug development services. The company delivers the largest volume of drug development data in the world, along with innovative technology, enabling the clients to identify new approaches and anticipate tomorrow's challenges as they evolve. It also offer laboratory testing services to the chemical, agrochemical and food industries, and provides toxicology, central laboratory, discovery and clinical trial management services.

Website
Formerly Known As
Corning Pharmaceutical Services
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 210 Carnegie Center
  • Princeton, NJ 08540
  • United States

+1 (609) 000-0000

Covance Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Covance‘s full profile, request access.

Request full access to PitchBook

Covance Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CrownBio Formerly PE-Backed Santa Clara, CA 000 00000 000000&0 00000
00000000000000 000 Private Equity-Backed Wilmington, NC 00000 00000 0000000 0000 00000
0000 000000 Formerly PE-Backed Shanghai, China 00000 00.000 0000 00.000
0000 0000000 00000 Formerly PE-Backed Concord, OH 00 000000&0
000 000000000000 Private Equity-Backed Kolkata, India 000000000000
To view this company’s complete list of competitors, request access »

Covance Investments & Acquisitions (11)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000000 29-Oct-2018 000000000000000000 Laboratory Services (Healthcare)
000 00000 & 000000 06-Aug-2015 000000000 00000 00 0000 Environmental Services (B2B) 000000 0000000
00000000 19-May-2014 000000000000000000 Consulting Services (B2B) 0000 000000 00
0000 000000000000 01-Sep-2011 000000000000000000 Discovery Tools (Healthcare) 00000 000000 00
Sanofi-Aventis (2 Operations in Porcheville and Alnwick) 29-Oct-2010 Merger/Acquisition 000.00 Drug Discovery 000000 0000000
To view this company’s complete investment and acquisition history, request access »

Covance Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 18-Dec-2008 000000000 Completed
  • 0000000
Noveprim 01-Mar-2004 Corporate 000.00 Completed
To view this company’s complete exits history, request access »

Covance Subsidiaries (2)

Company Name Industry Location Founded
PMI Preclinical Laboratory Services (Healthcare) San Carlos, CA 1983
0000000 0000000000 Corporate Pension Harrogate, United Kingdom
To view this company’s complete subsidiary history, request access »

Covance Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Covance‘s full profile, request access.

Request full access to PitchBook

Covance Executive Team (25)

Name Title Board
Seat
Contact
Info
John Ratliff Chief Executive Officer
Bill Hanlon Ph.D Group President of Clinical Development & Commercialization Services
Steven Anderson Ph.D Chief Scientific Officer
Virginia Deibel Ph.D Director of Microbiology
Mark Wilson International Commercial Director

17 Former Executives

You’re viewing 5 of 25 executives. Get the full list »

Covance Board Members (3)

Name Representing Role Since Contact
Info
00000 000000 Covance Director 000 0000

2 Former Board Members

You’re viewing 1 of 3 board members. Get the full list »